DIA adds new editor in chief

The Drug Information Association tapped Quintiles' J. Rick Turner as editor-in-chief of Drug Information Journal, the group's flagship journal for members. Under Turner's leadership, the journal will expand its coverage to medical devices and medical device and drug combination products, companion diagnostics and integrated pharmaceutical medicine, with a focus on regulatory science, according to a statement.
“While pharmaceutical medicine remains extremely important, the convergence of several lines of medical products plays a very large and potentially increasing role in improving human health in general,” Turner said in a statement.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.